Antidote and Seqster Join Hands To Advance Patient Identification

Antidote Technologies, a digital health firm that focuses on patient engagement to advance recruitment for clinical trials, and SEQSTER PDM Inc., the leading patient-centric healthcare technology company, declared an agreement to improve patient...

Unlock The Future Of Beauty At Cosmetics Ingredients Expo: Innovation, Sustainability & Industry Expertise On Display

Get ready for the highly anticipated Cosmetics Ingredients Expo 2024, a premier event that will bring together the best minds and leading innovators in the cosmetics industry.

Ligand Pharma To Acquire APEIRON Biologics For USD 100 Million

Ligand Pharmaceuticals, a biopharmaceutical company, delcared that it has forayed into a definitive contract to acquire APEIRON Biologics AG, which holds royalty rights to QARZIBA® (dinutuximab beta) for the treatment of high-risk neuroblastoma...

US FDA Nods Biostar Pharma's IND application For Phase 2 Study

Biostar Pharma, Inc., the US subsidiary of Beijing Biostar Pharmaceuticals Co., Ltd. (Biostar), a synthetic biology-driven biopharma firm focused on the creation and marketing of innovative oncology drugs, declared that the US FDA had approved...

Innovent Biologics and IASO Bio Join Hands For Cell Therapy

Innovative Biomedicals, Inc, a top notch biopharmaceutical organization that creates, manufactures and market great medications for the treatment of oncology, immune system, cardiovascular and metabolic, ophthalmology and other significant...

Roche Secures US FDA Nod For Vabysmo Prefilled Syringe

Roche, a leading pharmaceutical firm, declared the United States Food and Drug Administration (US FDA) has sanctioned the Vabysmo (faricimab) 6.0 mg single-dose prefilled syringe (PFS) for use in the treatment of neovascular or ‘wet’ age-related...

© 2024 India Pharma Outlook. All Rights Reserved.